- Human pathology

Home > D. General pathology > Therapy, Toxics and drugs > MEK1/2 inhibitors

MEK1/2 inhibitors

Thursday 4 March 2010


- The First-in-Human Study of the Hydrogen Sulfate (Hyd-Sulfate) Capsule of the MEK1/2 Inhibitor AZD6244 (ARRY-142886): A Phase I Open-Label Multicenter Trial in Patients with Advanced Cancer. Banerji U, Camidge DR, Verheul HM, Agarwal R, Sarker D, Kaye SB, Desar IM, Timmer-Bonte JN, Eckhardt SG, Lewis KD, Brown KH, Cantarini MV, Morris C, George SM, Smith PD, van Herpen CM. Clin Cancer Res. 2010 Mar 1;16(5):1613-23. PMID: 20179232